Legend Biotech Corp (LEGN) — Net Asset Quality Index
Legend Biotech Corp (LEGN) has a Net Asset Quality Index of 60.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.60 Billion minus total liabilities of $629.02 Million yields net assets of $967.73 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Legend Biotech Corp defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Legend Biotech Corp Net Asset Quality Index Over Time (2017–2025)
This chart shows how Legend Biotech Corp's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the index stands at 60.6%, representing net assets of $967.73 Million against total assets of $1.60 Billion USD. Explore how efficiently does Legend Biotech Corp generate cash to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Legend Biotech Corp (2017–2025)
The table below presents the year-by-year Net Asset Quality Index for Legend Biotech Corp from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Legend Biotech Corp stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 57.8% | $1.00 Billion | $1.73 Billion | $731.60 Million | ▼ -4.5 pp |
| 2024 | 62.3% | $1.04 Billion | $1.67 Billion | $629.61 Million | ▼ -5.4 pp |
| 2023 | 67.7% | $1.25 Billion | $1.85 Billion | $597.24 Million | ▲ +11.8 pp |
| 2022 | 55.9% | $744.31 Million | $1.33 Billion | $586.65 Million | ▼ -12.5 pp |
| 2021 | 68.4% | $765.94 Million | $1.12 Billion | $353.52 Million | ▼ -14.6 pp |
| 2020 | 83.1% | $599.82 Million | $722.09 Million | $122.27 Million | ▲ +125.8 pp |
| 2019 | -42.7% | $-122.87 Million | $287.71 Million | $410.58 Million | ▼ -44.7 pp |
| 2018 | 2.0% | $8.65 Million | $429.05 Million | $420.40 Million | ▼ -3.1 pp |
| 2017 | 5.1% | $12.17 Million | $238.69 Million | $226.53 Million | — |